At CBCC, we harness the power of cutting-edge technology to provide precise and timely
diagnoses for our patients. Our nuclear medicine department plays a pivotal role in this endeavor, utilising radiopharmaceuticals to offer non-invasive and highly informative diagnostic solutions.
Nuclear medicine is a specialised field that employs radioactive tracers (radiopharmaceuticals) for diagnosing and treating various diseases. These tracers are introduced into the body, allowing doctors to observe bodily functions and trace diseases using specialised cameras. The two primary imaging techniques in nuclear medicine are Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). SPECT is often used for diagnosing heart diseases and neurological disorders, while PET is crucial in cancer detection and monitoring. Importantly, the radiation dose from these procedures is typically low, comparable to standard medical imaging methods, and is considered safe relative to the benefits they provide.
Explore the world of nuclear medicine radiopharmaceuticals at CBCC and discover how we leverage innovation to transform cancer care. Your well-being is our priority, and we are dedicated to delivering excellence in diagnostics and treatment.
